These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1077759)

  • 1. Diphenylhydantoin treatment.
    Brown BI
    Arch Intern Med; 1975 May; 135(5):745. PubMed ID: 1077759
    [No Abstract]   [Full Text] [Related]  

  • 2. Diphenylhydantoin treatment of glycogen storage diseases.
    Jubiz W; Rallison ML
    Arch Intern Med; 1974 Sep; 134(3):418-21. PubMed ID: 4368592
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diphenylhydantoin (phenytoin)--a potent psychopharmaceutic drug?].
    Lund K
    Tidsskr Nor Laegeforen; 1968 Nov; 88(22):2137-9. PubMed ID: 5725143
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.
    Reynolds EH
    Proc R Soc Med; 1975 Feb; 68(2):102-4. PubMed ID: 1166035
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenytoin (diphenylhydantoin).
    Med Lett Drugs Ther; 1976 Feb; 18(5):23-4. PubMed ID: 1256358
    [No Abstract]   [Full Text] [Related]  

  • 6. [Scleroderma developing during treatment of ictal stupor with diphenylhydantoin].
    Kashiwazaki S; Goto T; Okada J; Tadenuma T; Tazaki Y
    Ryumachi; 1974 Oct; 14(3):220-8. PubMed ID: 4450153
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of diabetic neuropathy with diphenylhydantoin.
    Ellenberg M
    N Y State J Med; 1968 Oct; 68(20):2653-5. PubMed ID: 4300475
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of diphenylhydantoin.
    Simpson JF
    Ann Intern Med; 1973 Feb; 78(2):305-6. PubMed ID: 4683770
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with D-thyroxine of patients with glycogen storage diseases type VI and VIa.
    Cabalska B; Zbieg-Sendecka E; Kobryń A; Pronicka E; Pieniazek D
    Mater Med Pol; 1987; 19(4):290-3. PubMed ID: 3483883
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myopathia and hypothyroidism caused by diphenylhydantoin].
    Rabl W; Windorfer A
    Dtsch Med Wochenschr; 1977 Dec; 102(51):1895. PubMed ID: 598297
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications and surveillance of lignocaine and diphenylhydantoin treatments].
    Vogel M; Motté G
    Rev Prat; 1975 Oct; 25(45):3499-500, 3503-6, 3509-10 passim. PubMed ID: 1209117
    [No Abstract]   [Full Text] [Related]  

  • 12. [The place of diphenylhydantoin in the practice of heart therapy].
    Kaufmann G
    Ther Umsch; 1974 Feb; 31(2):78-83. PubMed ID: 4439349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of 2 modern antiarrhythmic drugs: lidocaine and diphenylhydantoin].
    Porciello PI; Zanini S; Poppi A
    G Ital Cardiol; 1972; 2(4):579-83. PubMed ID: 5050994
    [No Abstract]   [Full Text] [Related]  

  • 14. Diphenylhydantoin. Its usefulness in clinical disorders of a non-epileptic nature. Discussion on safety.
    Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:64-6. PubMed ID: 4870959
    [No Abstract]   [Full Text] [Related]  

  • 15. Diphenylhydantoin sodium in cardiac arrhythmias.
    Mathur KS; Wahal PK; Seth HC; Hazra DK
    J Indian Med Assoc; 1971 Oct; 57(7):256-8. PubMed ID: 5141453
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytogenetic study of diphenylhydantoin therapy using SCE].
    Sinués B; Martínez P; Tamparillas M; Bartolomé M
    Arch Farmacol Toxicol; 1982 Dec; 8(3):165-70. PubMed ID: 7183246
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal effects of maternal treatment with the anticonvulsant drug diphenylhydantoin.
    Watson JD; Spellacy WN
    Obstet Gynecol; 1971 Jun; 37(6):881-5. PubMed ID: 4378213
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphadenopathy associated with diphenylhydantoin therapy.
    Abratt RP; Sealy R; Uys CJ; Lawson R
    Clin Oncol; 1982 Dec; 8(4):351-6. PubMed ID: 7168928
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myasthenic syndrome following long-term diphenylhydantoin therapy].
    Milonas J; Kountouris D; Scheer E
    Nervenarzt; 1983 Aug; 54(8):437-8. PubMed ID: 6413870
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diphenylhydantoin: its use in cardiology].
    Acosta Varo M; Pérez de Ayala C; Mate Benito I; Ortiz Vázquez J
    Rev Clin Esp; 1973 Jun; 129(5):477-86. PubMed ID: 4732992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.